Iron addiction: a novel therapeutic target in ovarian cancer

D Basuli, L Tesfay, Z Deng, B Paul, Y Yamamoto… - Oncogene, 2017 - nature.com
Ovarian cancer is a lethal malignancy that has not seen a major therapeutic advance in over
30 years. We demonstrate that ovarian cancer exhibits a targetable alteration in iron …

Nanotransferrin-based programmable catalysis mediates three-pronged induction of oxidative stress to enhance cancer immunotherapy

S Bai, Z Lu, Y Jiang, X Shi, D Xu, Y Shi, G Lin, C Liu… - ACS …, 2021 - ACS Publications
Current oxidative stress amplifying strategies for immunogenic cell death (ICD) promotion
are mainly restricted to immune tolerance induced by adaptive cellular antioxidation, limited …

Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumors

SC Chafe, FS Vizeacoumar, G Venkateswaran… - Science …, 2021 - science.org
The metabolic mechanisms involved in the survival of tumor cells within the hypoxic niche
remain unclear. We carried out a synthetic lethal CRISPR screen to identify survival …

[HTML][HTML] Emerging agents that target signaling pathways in cancer stem cells

Y Yang, X Li, T Wang, Q Guo, T Xi, L Zheng - Journal of hematology & …, 2020 - Springer
Cancer stem cells (CSCs) contribute to the initiation, recurrence, and metastasis of cancer;
however, there are still no drugs targeting CSCs in clinical application. There are several …

Tumor abnormality-oriented nanomedicine design

Q Zhou, J Xiang, N Qiu, Y Wang, Y Piao… - Chemical …, 2023 - ACS Publications
Anticancer nanomedicines have been proven effective in mitigating the side effects of
chemotherapeutic drugs. However, challenges remain in augmenting their therapeutic …

FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels

V Trujillo-Alonso, EC Pratt, H Zong… - Nature …, 2019 - nature.com
Acute myeloid leukaemia is a fatal disease for most patients. We have found that ferumoxytol
(Feraheme), an FDA-approved iron oxide nanoparticle for iron deficiency treatment …

HSPB1 as a novel regulator of ferroptotic cancer cell death

X Sun, Z Ou, M Xie, R Kang, Y Fan, X Niu, H Wang… - Oncogene, 2015 - nature.com
Ferroptosis is an iron-dependent form of non-apoptotic cell death, but its molecular
mechanism remains largely unknown. Here, we demonstrate that heat shock protein beta-1 …

Ferroptosis nanomedicine: clinical challenges and opportunities for modulating tumor metabolic and immunological landscape

H Yang, X Yao, Y Liu, X Shen, M Li, Z Luo - ACS nano, 2023 - ACS Publications
Ferroptosis, a type of regulated cell death driven by iron-dependent phospholipid
peroxidation, has captured much attention in the field of nanomedicine since it was coined in …

Mitochondria and Iron: current questions

BT Paul, DH Manz, FM Torti, SV Torti - Expert review of hematology, 2017 - Taylor & Francis
Introduction: Mitochondria are cellular organelles that perform numerous bioenergetic,
biosynthetic, and regulatory functions and play a central role in iron metabolism …

Iron and cancer: recent insights

DH Manz, NL Blanchette, BT Paul… - Annals of the New …, 2016 - Wiley Online Library
Iron is an essential dietary element. However, the ability of iron to cycle between oxidized
and reduced forms also renders it capable of contributing to free radical formation, which …